🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2024-03-14
Trial ID
NCT05813327
Treatments Being Tested
The goal of this clinical research study is to find the highest safe dose o...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-08
Trial ID
NCT00147225
Treatments Being Tested
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
This is a multicenter, randomized, controlled, open-label Phase III clinica...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-06
Trial ID
NCT06792253
This study is a prospective, open label, randomized controlled clinical tri...
Status
Recruiting
Location
Fudan University Shanghai Cencer Center,
Start Date
2024-10-31
Trial ID
NCT06699472
Treatments Being Tested
Primary Objectives: 1. To determine the efficacy of in vivo purging achiev...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2004-01
Trial ID
NCT00499343
This phase II trial studies the effect of ascorbic acid and combination che...
Status
Recruiting
Location
Mayo Clinic Health Systems-Mankato
Start Date
2018-03-23
Trial ID
NCT03418038
Treatments Being Tested
This study utilizes a prospective, multicenter, randomized two-arm design t...
Status
Recruiting
Location
Dongyang People's Hospital
Start Date
2024-08-01
Trial ID
NCT06520163
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled (2: 1), multicenter ...
Status
Completed
Location
Tianjin Medical University Cancer Hospital & Institute
Start Date
2017-05-01
Trial ID
NCT03121833
Treatments Being Tested
Anlotinib is a multi-target receptor tyrosine kinase inhibitor. It can inhi...
Status
Unknown
Location
Liaoning Province Tumor Hospital
Start Date
2019-05-20
Trial ID
NCT03815474
Treatments Being Tested